Previously submitted to: Journal of Medical Internet Research (no longer under consideration since May 31, 2021)
Date Submitted: May 8, 2021
Open Peer Review Period: May 8, 2021 - May 31, 2021
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Digitazion in Gynaecology and Obstetrics in times of COVID-19: Results of a national survey
ABSTRACT
Background:
In the COVID-19 pandemic, many consultations had to be canceled, postponed or switched to a virtual format. Telemedicine in patient care management could support physicians.
Objective:
The study analyses the Acceptance, Use and Barriers of digital health applications (DHAs) in patients with gynecological diseases and gynecologists in Germany.
Methods:
This prospective cross-sectional study was based on a survey of gynaecologists and patients in Germany during the COVID-19 pandemic. Descriptive statistics were calculated and regression analyses were performed to show correlations.
Results:
We analyzed the responses of 490 patients and 478 gynecologists. Most believed that DHAs are useful and felt confident in their own usage thereof. The majority in both groups agreed on implementing virtual visits in stable disease conditions. Only a minority (<10% in both groups) believed that digitalization has a negative impact on the patient–doctor relationship. Patients and physicians reported that their attitude had changed positively towards DHAs and that their usage had increased due to COVID-19. The most reported advantage of DHAs were usage independent of time. The main barriers were a lack of information on suitable, available DHAs and a lack of evidence supporting the effectiveness of DHAs.
Conclusions:
The COVID-19 pandemic led to an increase in the acceptance and use of DHAs by patients and gynecologists, potentially leading to a permanent paradigm shift in the treatment of gynecological conditions.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.